Pfizer India has become the first pharmaceutical firm to seek from DCGI an emergency use authorisation for its coronavirus vaccine in the country.The extreme low temperature of minus 70 degrees Celsius required for storing the vaccine poses a big challenge for its delivery in a country like India
DISCLAIMER
All news items are for educational purposes only. The news content is hosted on the external news website. News item titles are derived from the original news title, news content, dialogue, speech or general content theme.
The above News Title may be edited and optimized for SEO, keyword density, information and internal website search purposes. You are advised to view the original news item for a better understanding.
If you spot any mistake, omission or to report abuse kindly
contact us.